chr3-149167992-A-AT

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_032383.5(HPS3):​c.2887+19dup variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13267 hom., cov: 0)
Exomes 𝑓: 0.27 ( 23925 hom. )

Consequence

HPS3
NM_032383.5 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.188
Variant links:
Genes affected
HPS3 (HGNC:15597): (HPS3 biogenesis of lysosomal organelles complex 2 subunit 1) This gene encodes a protein containing a potential clathrin-binding motif, consensus dileucine signals, and tyrosine-based sorting signals for targeting to vesicles of lysosomal lineage. The encoded protein may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 3. [provided by RefSeq, Apr 2015]
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 3-149167992-A-AT is Benign according to our data. Variant chr3-149167992-A-AT is described in ClinVar as [Benign]. Clinvar id is 343715.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.611 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HPS3NM_032383.5 linkuse as main transcriptc.2887+19dup intron_variant ENST00000296051.7 NP_115759.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HPS3ENST00000296051.7 linkuse as main transcriptc.2887+19dup intron_variant 1 NM_032383.5 ENSP00000296051 P1Q969F9-1

Frequencies

GnomAD3 genomes
AF:
0.396
AC:
59442
AN:
150124
Hom.:
13246
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.617
Gnomad AMI
AF:
0.312
Gnomad AMR
AF:
0.277
Gnomad ASJ
AF:
0.219
Gnomad EAS
AF:
0.372
Gnomad SAS
AF:
0.322
Gnomad FIN
AF:
0.391
Gnomad MID
AF:
0.260
Gnomad NFE
AF:
0.308
Gnomad OTH
AF:
0.351
GnomAD3 exomes
AF:
0.325
AC:
67084
AN:
206140
Hom.:
6184
AF XY:
0.321
AC XY:
35885
AN XY:
111620
show subpopulations
Gnomad AFR exome
AF:
0.549
Gnomad AMR exome
AF:
0.258
Gnomad ASJ exome
AF:
0.241
Gnomad EAS exome
AF:
0.363
Gnomad SAS exome
AF:
0.321
Gnomad FIN exome
AF:
0.361
Gnomad NFE exome
AF:
0.309
Gnomad OTH exome
AF:
0.315
GnomAD4 exome
AF:
0.266
AC:
301993
AN:
1135664
Hom.:
23925
Cov.:
18
AF XY:
0.268
AC XY:
154544
AN XY:
576444
show subpopulations
Gnomad4 AFR exome
AF:
0.501
Gnomad4 AMR exome
AF:
0.224
Gnomad4 ASJ exome
AF:
0.215
Gnomad4 EAS exome
AF:
0.330
Gnomad4 SAS exome
AF:
0.283
Gnomad4 FIN exome
AF:
0.339
Gnomad4 NFE exome
AF:
0.254
Gnomad4 OTH exome
AF:
0.278
GnomAD4 genome
AF:
0.396
AC:
59523
AN:
150240
Hom.:
13267
Cov.:
0
AF XY:
0.395
AC XY:
28963
AN XY:
73340
show subpopulations
Gnomad4 AFR
AF:
0.617
Gnomad4 AMR
AF:
0.277
Gnomad4 ASJ
AF:
0.219
Gnomad4 EAS
AF:
0.372
Gnomad4 SAS
AF:
0.324
Gnomad4 FIN
AF:
0.391
Gnomad4 NFE
AF:
0.308
Gnomad4 OTH
AF:
0.349
Bravo
AF:
0.395

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hermansky-Pudlak syndrome Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 02, 2019- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 25, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, outside ROI -
Deficiency of ferroxidase Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397710976; hg19: chr3-148885779; API